What ails the β-cell?

Diabetes, Obesity and Metabolism

Volumn 12, Issue SUPPL. 2, 2010, Pages 1-3

  Accili, D ^a   Ahren B ^b   Boitard, C ^c   Cerasi, E ^d   Henquin, J C ^e   Seino, S ^f  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CCAAT ENHANCER BINDING PROTEIN; FATTY ACID; UNCOUPLING PROTEIN 2;

AUTOPHAGY; CELL DEATH; CELL FUNCTION; DISEASE ASSOCIATION; EDITORIAL; ENDOPLASMIC RETICULUM; FATTY LIVER; HYPERGLYCEMIA; INSULIN RELEASE; INTRACELLULAR SIGNALING; MITOCHONDRION; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOGENICITY; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION;

EID: 77957293804     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01296.x     Document Type: Editorial

References (16)

1. Bell GI, Polonsky KS. Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 2001, 414:788-791..
2. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993, 76:44-48..
3. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999, 104:787-794..
4. Leahy JL. Mary, Mary, quite contrary, how do your beta-cells fail?. Diabetes 2008, 57:2563-2564..
5. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 2008, 10((Suppl. 4)):32-42..
6. Kahn SE, Haffner SM, Heise MA. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006, 355:2427-2443..
7. Singh R, Xiang Y, Wang Y. Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 2009, 119:3329-3339..
8. Choi SE, Lee SM, Lee YJ. Protective role of autophagy in palmitate-induced INS-1 beta-cell death. Endocrinology 2009, 150:126-134..
9. Jung HS, Chung KW, Won Kim J. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab 2008, 8:318-324..
10. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004, 279:42351-42354..
11. Scheuner D, Song B, McEwen E. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 2001, 7:1165-1176..
12. Matsuda T, Kido Y, Asahara S. Ablation of C/EBPbeta alleviates ER stress and pancreatic beta cell failure through the GRP78 chaperone in mice. J Clin Invest 2010, 120:115-126..
13. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119..
14. Echtay KS, Murphy MP, Smith RA, Talbot DA, Brand MD. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 2002, 277:47129-47135..
15. Pi J, Bai Y, Daniel KW. Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function. Endocrinol 2009, 150:3040-3048..
16. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006, 116:1802-1812..